Dietary prevention of antibiotic-induced dysbiosis and mortality upon aging in mice

FASEB J. 2024 Dec 15;38(23):e70241. doi: 10.1096/fj.202402262R.

Abstract

Oral antibiotic use is both widespread and frequent in older adults and has been linked to dysbiosis of the gut microbiota, enteric infection, and chronic diseases. Diet and nutrients, particularly prebiotics, may modify the susceptibility of the gut microbiome to antibiotic-induced dysbiosis. We fed 12-month-old mice a high glycemic (HG) or low glycemic (LG) diet with or without antibiotics (ampicillin and neomycin) for an additional 11 months. The glycemic index was modulated by the ratio of rapidly digested amylopectin starch to slowly digested amylose, a type-2-resistant starch. We observed a significant decrease in survival of mice fed a HG diet containing antibiotics (HGAbx) relative to those fed a LG diet containing antibiotics (LGAbx). HGAbx mice died with an enlarged and hemorrhagic cecum, which is associated with colonic hyperplasia and goblet cell depletion. Gut microbiome analysis revealed a pronounced expansion of Proteobacteria and a near-complete loss of Bacteroidota and Firmicutes commensal bacteria in HGAbx, whereas the LGAbx group maintained a population of Bacteroides and more closely resembled the LG microbiome. The predicted functional capacity for bile salt hydrolase activity was lost in HGAbx mice but retained in LGAbx mice. An LG diet containing amylose may therefore be a potential therapeutic to prevent antibiotic-induced dysbiosis and morbidity.

Keywords: aging; antibiotic; gastrointestinal disease; glycemic index; inflammation; microbiome; resistant starch; survival.

MeSH terms

  • Aging*
  • Animals
  • Anti-Bacterial Agents* / pharmacology
  • Diet
  • Dysbiosis* / chemically induced
  • Gastrointestinal Microbiome* / drug effects
  • Male
  • Mice
  • Mice, Inbred C57BL

Substances

  • Anti-Bacterial Agents